Publication

Byline

Location

US Patent Issued to KEZAR LIFE SCIENCES on April 14 for "Triazacyclododecansulfonamide (TCD)-based protein secretion inhibitors" (California Inventor)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,711, issued on April 14, was assigned to KEZAR LIFE SCIENCES INC. (South San Francisco, Calif.). "Triazacyclododecansulfonamide (TCD)-base... और पढ़ें


US Patent Issued to Hoffmann-La Roche on April 14 for "Amino-pyrimidine amides" (French, Swiss, German Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,712, issued on April 14, was assigned to Hoffmann-La Roche Inc. (Little Falls, N.J.). "Amino-pyrimidine amides" was invented by Angelica B... और पढ़ें


US Patent Issued to Hutchmed on April 14 for "Crystalline forms of 6-((6,7-dimethoxyquinazolin-4-yl)oxy)-N,2-dimethylbenzofuran-3-carboxamide" (Chinese Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,713, issued on April 14, was assigned to Hutchmed Ltd. (Shanghai). "Crystalline forms of 6-((6,7-dimethoxyquinazolin-4-yl)oxy)-N,2-dimethy... और पढ़ें


US Patent Issued to WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) on April 14 for "Substituted pyrazinecarboxamide compounds for treating diseases related to EGFR mutation" (Chinese Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,714, issued on April 14, was assigned to WIGEN BIOMEDICINE TECHNOLOGY (SHANGHAI) Co. LTD. (Shanghai). "Substituted pyrazinecarboxamide com... और पढ़ें


US Patent Issued to Boehringer Ingelheim International on April 14 for "Soluble guanylate cyclate activators for treating systemic sclerosis" (New York, Connecticut Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,715, issued on April 14, was assigned to Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany). "Soluble guanylate cyclate... और पढ़ें


US Patent Issued to Gannex Pharma on April 14 for "Compounds for modulating activity of FXR and uses thereof" (Chinese Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,716, issued on April 14, was assigned to Gannex Pharma Co. Ltd. (Shanghai). "Compounds for modulating activity of FXR and uses thereof" wa... और पढ़ें


US Patent Issued to Incyte on April 14 for "Tricyclic compounds as inhibitors of KRAS" (Delaware, Pennsylvania, New Jersey Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,717, issued on April 14, was assigned to Incyte Corp. (Wilmington, Del.). "Tricyclic compounds as inhibitors of KRAS" was invented by Zhen... और पढ़ें


US Patent Issued to BORYUNG on April 14 for "Method for preparing compound as PI3K inhibitor and intermediate compound for preparing same" (South Korean Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,718, issued on April 14, was assigned to BORYUNG Corp. (Seoul, South Korea). "Method for preparing compound as PI3K inhibitor and intermed... और पढ़ें


US Patent Issued to The General Hospital on April 14 for "Salt inducible kinase inhibitors" (New Jersey, Massachusetts Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,719, issued on April 14, was assigned to The General Hospital Corp. (Boston). "Salt inducible kinase inhibitors" was invented by Marc Nath... और पढ़ें


US Patent Issued to Evotec International on April 14 for "Modulators of the integrated stress response pathway" (British Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,720, issued on April 14, was assigned to Evotec International GmbH (Hamburg, Germany). "Modulators of the integrated stress response pathw... और पढ़ें